Literature DB >> 16477040

MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.

Christopher N Davis1, Enrique Mann, M Margarita Behrens, Svetlana Gaidarova, Mitra Rebek, Julius Rebek, Tamas Bartfai.   

Abstract

Interleukin (IL)-1beta is a pluripotent proinflammatory cytokine that signals through the type-I IL-1 receptor (IL-1RI), a member of the Toll-like receptor family. In hypothalamic neurons, binding of IL-1beta to IL-1RI mediates transcription-dependent changes that depend on the recruitment of the cytosolic adaptor protein myeloid differentiation primary-response protein 88 (MyD88) to the IL-1RI/IL-1 receptor accessory protein (IL-1RAcP) complex through homomeric Toll/IL-1 receptor (TIR)-TIR interactions. Through design and synthesis of bifunctional TIR mimetics that disrupt the interaction of MyD88 with the IL-1RI/IL-1RAcP complex, we analyzed the involvement of MyD88 in the signaling of IL-1beta in anterior hypothalamic neurons. We show here that IL-1beta-mediated activation of the protein tyrosine kinase Src depended on a MyD88 interaction with the IL-1RI/IL-1RAcP complex. The activation of the protein kinase Akt/PKB depended on the recruitment of the p85 subunit of PI3K to IL-1RI and independent of MyD88 association with the IL-1RI/IL-1RAcP complex. These bifunctional TIR-TIR mimetics represent a class of low-molecular-weight compounds with both an antiinflammatory and neuroprotective potential. These compounds have the potential to inhibit the MyD88-dependent proinflammatory actions of IL-1beta, while permitting the potential neuronal survival supporting actions mediated by the MyD88-independent activation of the protein kinase Akt.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477040      PMCID: PMC1413805          DOI: 10.1073/pnas.0510802103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.

Authors:  L O'Neill
Journal:  Biochem Soc Trans       Date:  2000-10       Impact factor: 5.407

Review 2.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 3.  Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases.

Authors:  Snezana Djordjevic; Paul C Driscoll
Journal:  Trends Biochem Sci       Date:  2002-08       Impact factor: 13.807

4.  A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.

Authors:  L A Madge; J S Pober
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Authors:  M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

6.  IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK).

Authors:  X Li; M Commane; Z Jiang; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 7.  The role of MyD88-like adapters in Toll-like receptor signal transduction.

Authors:  L A J O'Neill
Journal:  Biochem Soc Trans       Date:  2003-06       Impact factor: 5.407

8.  Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons.

Authors:  Valerie Heidinger; Pat Manzerra; Xue Qing Wang; Uta Strasser; Shan-Ping Yu; Dennis W Choi; M Margarita Behrens
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  IL-1beta-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1.

Authors:  Detlef Neumann; Stefan Lienenklaus; Olaf Rosati; Michael U Martin
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

Review 10.  Microglia as a source and target of cytokines.

Authors:  Uwe-Karsten Hanisch
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  43 in total

1.  Distinct control of MyD88 adapter-dependent and Akt kinase-regulated responses by the interleukin (IL)-1RI co-receptor, TILRR.

Authors:  Xiao Zhang; Gemma Montagut Pino; Freya Shephard; Endre Kiss-Toth; Eva E Qwarnstrom
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

2.  Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.

Authors:  Jiang Qian; Ling Zhu; Qiming Li; Natalya Belevych; Qun Chen; Fangli Zhao; Scott Herness; Ning Quan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis.

Authors:  Hideo Yoshida; Janice Russell; Elena Y Senchenkova; Lidiana D Almeida Paula; D Neil Granger
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

4.  Heterocyclic alpha-helix mimetics for targeting protein-protein interactions.

Authors:  Shannon M Biros; Lionel Moisan; Enrique Mann; Alexandre Carella; Dayong Zhai; John C Reed; Julius Rebek
Journal:  Bioorg Med Chem Lett       Date:  2007-05-27       Impact factor: 2.823

Review 5.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

Review 6.  TLR8: an innate immune receptor in brain, neurons and axons.

Authors:  Yinghua Ma; Robin L Haynes; Richard L Sidman; Timothy Vartanian
Journal:  Cell Cycle       Date:  2007-09-04       Impact factor: 4.534

7.  A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.

Authors:  Silvia Balosso; Mattia Maroso; Manuel Sanchez-Alavez; Teresa Ravizza; Angelisa Frasca; Tamas Bartfai; Annamaria Vezzani
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

8.  Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.

Authors:  Kenji Funami; Miwa Sasai; Hiroyuki Oshiumi; Tsukasa Seya; Misako Matsumoto
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

Review 9.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

Review 10.  Fever.

Authors:  Tamas Bartfai; Bruno Conti
Journal:  ScientificWorldJournal       Date:  2010-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.